Evaluation of Direct Cost of Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus Positive Patients

Journal Title: Journal of Clinical Research in HIV AIDS and Prevention - Year 2012, Vol 1, Issue 1

Abstract

In India, interruptions to highly active antiretroviral therapy (HAART) are due to adverse drug reactions (ADRs) and no reports on the direct cost incurred in the management of ADRs to HAART are available. There is a need to study direct cost incurred with ADRs to HAART to explore the high economic cost burden imposed by ADRs to HAART in HIV/AIDS patients. This study was aimed to evaluate the direct cost incurred in the management of ADRs to HAART in Indian HIV positive patients. This prospective study was conducted at a Medicine department in a South Indian tertiary care teaching hospitals were ADRs reporting system exist. HIV-positive hospitalized in-patients were identified and intensively monitored for ADRs to HAART. The World Health Organization (WHO) probability scale was used for causality assessment of ADRs. Modified Hart wig and Siegel scale was used for severity assessment of ADRs.Pearson chi-square test identified association of mean direct cost between ADRs and without ADRs by investigating total mean direct cost. The overall direct cost per ADRs to HAART was found to be higher in the context of expenditure on health care cost in India.

Authors and Affiliations

Radhakrishnan Rajesh, Sudha Vidyasagar, Danturulu Muralidhar Varma, Noor unnisa, Vasudeva Guddattu

Keywords

Related Articles

Disability and Health Outcomes – From a Cohort of People on Long Term ART

HIV and AIDS remains a major health problem in South Africa even after two decades since the introduction of antiretroviral therapy. Long term survival with HIV is associated with new health related issues and a risk of...

Socio-Economic and Demographic Pattern of HIV Occurrence Amongst Attendees in a Tertiary Care Hospital in Eastern India.

Objective: Toanalyze the socio-economic pattern amongst HIV patients in eastern and north-eastern India as measured by different parameters such as educational status, wealth, marital status, sexual behaviour. Methods:...

Supporting Quality Data Systems: Lessons Learned from Early Implementation of Routine Viral Load Monitoring at a Large Clinic in Lilongwe, Malawi

Successful viral load programs rely on the presence of data systems and high quality of patient data. Using a cohort of 49 patients at Partners in Hope, a large, urban HIV clinic in Malawi, we performed a quality improve...

Evaluation of Recruitment Approaches for the HPTN 052 Clinical Trial of HIV Serodiscordant Couples in Rural Western Kenya

Recruitment of couples is important for study success. The multi-centered HPTN 052 clinical trial was designed to evaluate whether immediate versus delayed use of ART by HIV-infected individuals would reduce transmission...

Download PDF file
  • EP ID EP262731
  • DOI 10.14302/issn.2324-7339.jcrhap-12-71
  • Views 132
  • Downloads 0

How To Cite

Radhakrishnan Rajesh, Sudha Vidyasagar, Danturulu Muralidhar Varma, Noor unnisa, Vasudeva Guddattu (2012). Evaluation of Direct Cost of Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus Positive Patients. Journal of Clinical Research in HIV AIDS and Prevention, 1(1), 12-21. https://europub.co.uk/articles/-A-262731